MedTrace Logo

Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MRI

NCT02550366 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2024-01-23

No results posted yet for this study

Summary

Coronary artery disease (CAD) is the leading cause of death in the United States. Cardiac MRI is a non-invasive non-ionizing technique for a comprehensive cardiac exam, which can be used in the diagnosis of CAD. In this work, the investigators will develop and validate techniques for accelerated cardiac MRI, offering better volumetric coverage of the heart, improved contrast, and superior spatial and temporal resolutions.

Conditions

  • Cardiac Disease

Interventions

DRUG

MRI Contrast

MRI Contrast

Sponsors & Collaborators

Principal Investigators

  • Mehmet Akcakaya, PhD · University of Minnesota

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2024-01-19
Completion
2024-01-19
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02550366 on ClinicalTrials.gov